Target intelligence / Profile preview

PEX5L antisense RNA 1 (PEX5L-AS1)

Target
PEX5L-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

PEX5L antisense RNA 1 (PEX5L-AS1) is a long non-coding RNA (lncRNA) that is transcribed antisense to the PEX5L gene locus. Antisense lncRNAs are generally characterized by roles in regulating gene expression through complementary base pairing with sense transcripts, which can influence stability, splicing, localization, or translation of the paired mRNA. There is limited specific functional or mechanistic information available about PEX5L-AS1 itself; current knowledge reflects broader understanding of antisense lncRNAs rather than unique data for this gene. There are no drugs, therapeutic interventions, or well-established disease links for PEX5L-AS1. It is not considered a canonical therapeutic target such as a receptor, enzyme, transporter, or established biomarker. Existing research focuses on its identification and possible expression changes in some disease states (such as cancer transcriptomics analyses), but there is no evidence that it functions as a drug target or plays a direct role in established pathophysiological mechanisms.

02

Mechanism of action

Not applicable; no known drugs target PEX5L-AS1 directly

03

Biological functions

Regulation of gene expression via antisense interactionPotential involvement in mRNA transport and stability (general for antisense RNAs)Putative roles in modulating expression of the neighboring PEX5L gene
04

Disease associations

Preliminary evidence suggests expression in certain cancers, but there is no strong disease association specifically for PEX5L-AS1 as of the latest data

Beyond the preview

Go deeper on PEX5L antisense RNA 1 (PEX5L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PEX5L antisense RNA 1 (PEX5L-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call